Plant ID: NPO2161
Plant Latin Name: Strychnos ledermannii
Taxonomy Genus: Strychnos
Taxonomy Family: Loganiaceae
NCBI TaxonomyDB:
n.a.
Plant-of-the-World-Online:
n.a.
GPBAR1; | |
TSHR; | |
PTPN1; PTPN2; CDC25B; | |
GLA; PLA2G1B; TDP1; AKR1B10; ALOX15; POLB; | |
CA2; CA1; CA12; CA9; CA3; CA14; CA7; CA5A; CA6; | |
NR1H4; | |
CASP1; CASP7; | |
HIF1A; TP53; NFKB1; | |
HTT; | |
XDH; |
Cytochrome P450 Enzymes: | CYP2C19; |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cysteine protease | CASP1 | Caspase-1 | P29466 | CHEMBL4801 |
Cysteine protease | CASP7 | Caspase-7 | P55210 | CHEMBL3468 |
Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
Enzyme_unclassified | GLA | Alpha-galactosidase A | P06280 | CHEMBL2524 |
Enzyme_unclassified | PLA2G1B | Phospholipase A2 group 1B | P04054 | CHEMBL4426 |
Enzyme_unclassified | TDP1 | Tyrosyl-DNA phosphodiesterase 1 | Q9NUW8 | CHEMBL1075138 |
Enzyme_unclassified | AKR1B10 | Aldo-keto reductase family 1 member B10 | O60218 | CHEMBL5983 |
Enzyme_unclassified | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
Enzyme_unclassified | POLB | DNA polymerase beta | P06746 | CHEMBL2392 |
Lyase | CA2 | Carbonic anhydrase II | P00918 | CHEMBL205 |
Lyase | CA1 | Carbonic anhydrase I | P00915 | CHEMBL261 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA9 | Carbonic anhydrase IX | Q16790 | CHEMBL3594 |
Lyase | CA3 | Carbonic anhydrase III | P07451 | CHEMBL2885 |
Lyase | CA14 | Carbonic anhydrase XIV | Q9ULX7 | CHEMBL3510 |
Lyase | CA7 | Carbonic anhydrase VII | P43166 | CHEMBL2326 |
Lyase | CA5A | Carbonic anhydrase VA | P35218 | CHEMBL4789 |
Lyase | CA6 | Carbonic anhydrase VI | P23280 | CHEMBL3025 |
Nuclear hormone receptor subfamily 1 group H | NR1H4 | Bile acid receptor FXR | Q96RI1 | CHEMBL2047 |
Oxidoreductase | XDH | Xanthine dehydrogenase | P47989 | CHEMBL1929 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Protein Phosphatase | PTPN1 | Protein-tyrosine phosphatase 1B | P18031 | CHEMBL335 |
Protein Phosphatase | PTPN2 | T-cell protein-tyrosine phosphatase | P17706 | CHEMBL3807 |
Protein Phosphatase | CDC25B | Dual specificity phosphatase Cdc25B | P30305 | CHEMBL4804 |
Small molecule receptor (family A GPCR) | GPBAR1 | G-protein coupled bile acid receptor 1 | Q8TDU6 | CHEMBL5409 |
Transcription Factor | HIF1A | Hypoxia-inducible factor 1 alpha | Q16665 | CHEMBL4261 |
Transcription Factor | TP53 | Cellular tumor antigen p53 | P04637 | CHEMBL4096 |
Transcription Factor | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | P19838 | CHEMBL3251 |
Unclassified | HTT | Huntingtin | P42858 | CHEMBL5514 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0005488; binding | GO:0008270; zinc ion binding | 1.185E-08 | 2.346E-05 | CA1, CA12, CA2, CA3, CA5A, CA6, CA7, CA9, NR1H4, PTPN1, TP53 |
BP | GO:0009987; cellular process | GO:0032849; positive regulation of cellular pH reduction | 6.523E-06 | 5.073E-03 | CA2, CA7 |
BP | GO:0009987; cellular process | GO:0038183; bile acid signaling pathway | 6.523E-06 | 5.073E-03 | GPBAR1, NR1H4 |
MF | GO:0060089; molecular transducer activity | GO:0038181; bile acid receptor activity | 6.523E-06 | 5.073E-03 | GPBAR1, NR1H4 |
BP | GO:0065007; biological regulation | GO:0050790; regulation of catalytic activity | 1.006E-05 | 7.301E-03 | CASP1, CASP7, CDC25B, GLA, HIF1A, HTT, NFKB1, PLA2G1B, PTPN1, PTPN2, TP53, TSHR, XDH |
BP | GO:0009987; cellular process | GO:1902202; regulation of hepatocyte growth factor receptor signaling pathway | 1.303E-05 | 8.601E-03 | PTPN1, PTPN2 |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 4.841E-23 | 1.054E-18 | CA1, CA12, CA14, CA2, CA3, CA5A, CA6, CA7, CA9 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 6.674E-18 | 5.719E-14 | CA1, CA12, CA14, CA2, CA3, CA5A, CA6, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 2.634E-16 | 1.147E-12 | CA1, CA12, CA2, CA3, CA5A, CA6, CA7, CA9 |
MF | GO:0003824; catalytic activity | GO:0004064; arylesterase activity | 3.252E-05 | 1.574E-02 | CA1, CA2 |
MF | GO:0005488; binding | GO:0019900; kinase binding | 4.263E-05 | 1.807E-02 | CASP1, CDC25B, HIF1A, HTT, PTPN1, PTPN2, TP53 |
CC | GO:0044464; cell part | GO:0005829; cytosol | 1.237E-04 | 3.499E-02 | AKR1B10, ALOX15, CA1, CA2, CA3, CA7, CASP1, CASP7, CDC25B, HIF1A, HTT, NFKB1, PLA2G1B, PTPN1, PTPN2, TP53, XDH |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 1.716E-22 | 1.871E-20 | CA12, CA1, CA3, CA2, CA5A, CA7, CA6, CA9, CA14 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 9.765E-06 | 5.322E-04 | PLA2G1B, ALOX15, CYP2C19 |
09160 Human Diseases | 09167 Infectious diseases | hsa05134 | Legionellosis | 6.835E-05 | 2.483E-03 | CASP7, CASP1, NFKB1 |
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 9.787E-05 | 2.667E-03 | PLA2G1B, ALOX15, CYP2C19 |
09160 Human Diseases | 09167 Infectious diseases | hsa05133 | Pertussis | 1.725E-04 | 3.761E-03 | CASP7, CASP1, NFKB1 |
09140 Cellular Processes | 09143 Cell growth and death | hsa04210 | Apoptosis | 1.074E-03 | 1.672E-02 | CASP7, TP53, NFKB1 |
09160 Human Diseases | 09161 Cancers | hsa05203 | Viral carcinogenesis | 3.186E-03 | 3.270E-02 | POLB, TP53, NFKB1 |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00052 | Galactose metabolism | 8.611E-04 | 1.564E-02 | AKR1B10, GLA |
09160 Human Diseases | 09163 Neurodegenerative diseases | hsa05014 | Amyotrophic lateral sclerosis (ALS) | 2.477E-03 | 3.270E-02 | CASP1, TP53 |
09100 Metabolism | 09103 Lipid metabolism | hsa00561 | Glycerolipid metabolism | 3.300E-03 | 3.270E-02 | AKR1B10, GLA |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
C00-D49: Neoplasms | Colorectal cancer | C18-C21 | TP53; |
E00-E89: Endocrine, nutritional and metabolic diseases | Type 2 diabetes | E11 | NFKB1; |
C00-D49: Neoplasms | Late-stage solid tumors | C00-C75, C7A, C7B, D10-D36, D3A | TP53; |
C00-D49: Neoplasms | Hematological malignancies | C81-C86 | TP53; |
C00-D49: Neoplasms | Oral cavity cancer | C00-C08 | TP53; |
I00-I99: Diseases of the circulatory system | Renal artery disease | I70.1 | TP53; |
C00-D49: Neoplasms | Cancer | C00-C96 | NFKB1; TP53; CDC25B; |
C00-D49: Neoplasms | Acute myeloid leukemia | C92.0 | TP53; |
C00-D49: Neoplasms | Head and neck cancer | C07-C14, C32-C33 | TP53; |
H60-H95: Diseases of the ear and mastoid process | Hearing disorder | H90.5 | TP53; |
S00-T88: Injury, poisoning and certain other consequences of external causes | Toxicity | T36-T50, T51-T65 | TP53; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | TP53; |